Pharmaceutical Contract Manufacturing Organization

Renaissance develops and manufactures high-quality pharmaceuticals to fulfill your patients’ needs.

Your Partner for Nasal Sprays

State-of-the-art laboratory

Cutting edge spray characterization instruments, almost 20 years in nasal experience, and successful commercialization of products for the US and global markets, Renaissance is the “one-stop-shop” for all your nasal spray formulation, development, testing, and commercialization needs.

LEARN MORE

Trusted, Reliable Contract Manufacturing

World-class sterile liquid manufacturing

Renaissance is a global, pure-play contract development and manufacturing organization (“CDMO”) leader with an unparalleled bench-to-shelf service offering for nasal and sterile injectable dosage forms.

LEARN MORE

1979

Where it all started. Paco Packaging & Labs relocates to Paco Way in Lakewood, NJ from Philadelphia, PA.

LEARN MORE
pharmaceutical vials on assembly line
Trusted & Reliable Manufacturing

Our Capabilities Overview

Watch Video

News & Events

Our newest offerings and capabilities. Recent investments in our facilities, new and expanded services and expertise. Upcoming conferences and events.
Insights

April 24, 2024

Q&A: The role of CDMOs in overcoming nasal drug delivery R&D and manufacturing challenges

Rohit Mulik, Senior Manager: Formulation R&D, and Eric Kaneps, VP, Sales & Marketing at Renaissance Lakewood LLC, answer questions about the challenges in nasal drug delivery and outline how CDMO partnerships can help to overcome them.

READ MORE
News

April 23, 2024

Q&A with European Pharmaceutical Manufacturer Magazine

In an interview with Jai McIntosh, Editor for EPM, Eric Kaneps, VP, Sales and Marketing at Renaissance Lakewood explores how innovation has been at the heart of the success of the company and the market. He also provides his unique insights into some of the challenges nasal spray developers are currently facing.

READ MORE
News Insights

February 21, 2024

Application Note

Supporting nasal product R&D and clinical manufacturing at Renaissance

READ MORE

+$30m

+$30 million in facilities and equipment investments since 2020

1st

Manufacturer of the first FDA approved bi-dose nasal spray drug

310k

Sq. ft. of infrastructure with additional space under construction

+10

cGMP manufacturing suites with additional under construction